SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
July 31, 2026 0.0585M
April 30, 2026 0.0238M
January 31, 2026 0.007M
Date Value
October 31, 2025 0.00
April 30, 2025 0.00
October 31, 2024 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
AbbVie, Inc. 14.67B
Vericel Corp. 180.98M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B
Anika Therapeutics, Inc. 52.67M